All of the September 9 enforcement letters citing DTC promotional content were issued at the center-level by the Center for Drug Evaluation and Research (CDER) or the Center for Biologics Evaluation ...
U.S. Food and Drug Administration "enforcement in the social media space has historically been somewhat limited, but recent ...
On September 16, 2025, the U.S. Food and Drug Administration (FDA) released more than 60 warning letters sent to specific pharmaceutical manufacturers, alleging misbranding of a particular drug ...
Following the FDA’s September announcement of a crackdown on direct-to-consumer drug marketing practices and the subsequent flurry of untitled and warning letters criticizing dozens of Big Pharma ads, ...
The FDA is seeking (PDF) new powers to hold companies accountable for misleading direct-to-consumer (DTC) ads, adding legislat | The FDA is seeking new powers to hold companies accountable for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results